GobyMeds vs Noom Med
GobyMeds and Noom Med sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
GobyMeds
Best for: moving between compounded and brand without changing seller
Visit GobyMeds →
If you are choosing between GobyMeds and Noom Med, price alone will not settle it. GobyMeds leads our six-part score, 8.3 to 4.1.
GobyMeds vs Noom Med price
GobyMeds and Noom Med start at the same figure, $99 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Medications and formats
GobyMeds lists semaglutide and tirzepatide; Noom Med does not name its drug.
On format, GobyMeds prices compounded injections and brand-name pens, while Noom Med posts no priced format.
If you want the FDA-approved brand rather than a compounded version, GobyMeds is the only one of the two with a brand-name price.
Where each one treats patients
Neither GobyMeds nor Noom Med publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
GobyMeds
$299 total for 12 weeks incl. medication, shipping, consultation, injection kit; JUMPSTART20 promo $279 total ($93/mo) — promo end-dated Dec 31 2025 but still displayed July 2026
$399 total / 12 weeks
$499 total / 12 weeks; JUMPSTART PROMO PRICE $439 ($146/month) shown under the higher-dose block
JUMPSTART20 promo $159
$399 total for 12 weeks incl. medication, shipping, consultation, injection kit; promo price shown unchanged at $399
$499 total / 12 weeks
$599 total / 12 weeks; JUMPSTART PROMO PRICE $479+ (price dependent on dose)
Primary pricing block says $299 (promo $279); a duplicated template block on the same page shows $349 — site inconsistency
Promo codes 'not valid on Zepbound and Wegovy'
Promo codes 'not valid on Zepbound and Wegovy'
Noom Med
What each price covers
GobyMeds' price also covers the clinician visit, the medication itself and shipping, which Noom Med does not claim.
GobyMeds is silent on lab work and coaching.
Noom Med does not say what its price includes.
That matters most for the drug: unless Noom Med confirms otherwise, budget for medication on top of its listed price.
GobyMeds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Noom Med
Inclusions not disclosed.
Where each one scores higher
Overall, GobyMeds scores 8.3 and Noom Med 4.1 out of 10.
GobyMeds is stronger on value (9.6 vs 3.0), effectiveness (10.0 vs 5.0), user experience (8.0 vs 3.0), trust & safety (6.5 vs 4.0) and support (7.0 vs 5.0).
Accessibility is within half a point.
GobyMeds
8.3/10
Noom Med
4.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GobyMeds nor Noom Med has an FDA warning letter on record with us.
Features & Coverage
| Feature | GobyMeds | Noom Med |
|---|---|---|
| Starting Price | $99/mo | $99/mo |
| Features | 2 features | ✓3 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About GobyMeds
GobyMeds is a low-cost telehealth seller. Compounded semaglutide is the only medication it offers.
Read our full GobyMeds review →About Noom Med
Noom Med pairs GLP-1 medication access with Noom's cognitive behavioral therapy curriculum, 1-on-1 dietitian coaching, and a dedicated care team. Noom calls that curriculum proven and bills the combination as the most comprehensive psychology-plus-medication program available.
Read our full Noom Med review →Pros & Cons
GobyMeds
What we like
- Semaglutide costs $99 a month, 46% below the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $133 a month, 47% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to GobyMeds
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Noom Med
What we like
- We found no FDA warning letters issued to Noom Med
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
GobyMeds wins this one, 8.3 to 4.1, above all for moving between compounded and brand without changing seller.
Choose GobyMeds if…
You want moving between compounded and brand without changing seller and an opening price near $99 a month.
Choose Noom Med if…
You want the lower starting price and an opening price near $99 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
RxSpan MD
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $249/mo
Get started →Luvo Health
Moving between compounded and brand without changing seller
From $249/mo
Get started →Strut Health
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →GobyMeds vs Noom Med: FAQ
Close alternatives to GobyMeds and Noom Med
- GobyMeds vs HeliMeds
- GobyMeds vs Aspire Health
- GobyMeds vs Good Girl Rx
- GobyMeds vs Measured
- Noom Med vs CoreAge Rx
- Noom Med vs bmiMD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.